Lung Function Trajectories and Associated Mortality among Adults with and without Airway Obstruction.

Abstract

<b>Rationale:</b> Spirometry is essential for diagnosis and assessment of prognosis in patients with chronic obstructive pulmonary disease (COPD). <b>Objectives:</b> To identify FEV₁ trajectories and their determinants on the basis of annual spirometry measurements among individuals with and without airway obstruction (AO) and to assess mortality in relation to trajectories. <b>Methods:</b> From 2002 through 2004, individuals with AO (FEV₁/VC < 0.70, <i>n</i> = 993) and age- and sex-matched nonobstructive (NO) referents were recruited from population-based cohorts. Annual spirometry until 2014 was used in joint-survival latent-class mixed models to identify lung function trajectories. Mortality data were collected during 15 years of follow-up. <b>Measurements and Main Results:</b> Three trajectories were identified among the subjects with AO and two among the NO referents. Trajectory membership was driven by baseline FEV₁% predicted (FEV₁%pred) in both groups and also by pack-years in subjects with AO and current smoking in NO referents. Longitudinal FEV₁%pred depended on baseline FEV₁%pred, pack-years, and obesity. The trajectories were distributed as follows: among individuals with AO, 79.6% in AO trajectory 1 (FEV₁ high with normal decline), 12.8% in AO trajectory 2 (FEV₁ high with rapid decline), and 7.7% in AO trajectory 3 (FEV₁ low with normal decline) (mean, 27, 72, and 26 ml/yr, respectively) and, among NO referents, 96.7% in NO trajectory 1 (FEV₁ high with normal decline) and 3.3% in NO trajectory 2 (FEV₁ high with rapid decline) (mean, 34 and 173 ml/yr, respectively). Hazard for death was increased for AO trajectories 2 (hazard ratio [HR], 1.56) and 3 (HR, 3.45) versus AO trajectory 1 and for NO trajectory 2 (HR, 2.99) versus NO trajectory 1. <b>Conclusions:</b> Three different FEV₁ trajectories were identified among subjects with AO and two among NO referents, with different outcomes in terms of FEV₁ decline and mortality. The FEV₁ trajectories among subjects with AO and the relationship between low FVC and trajectory outcome are of particular clinical interest.